文献速递造血干细胞移植与细胞治疗

预存供者特异性HLA抗体对未处理单倍体相合造血干细胞移植植入失败的影响

[Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2018-01-01

该研究采用免疫磁珠液相芯片技术检测92例拟行单倍体相合造血干细胞移植患者的HLA抗体,分析DSA与植入失败的相关性及处理方法。常规清髓性预处理移植中,DSA阴性组植入率92.3%(24/26)显著高于DSA阳性组25.0%(1/4)(χ²=8.433,P=0.004),多因素分析显示DSA是影响植入的唯一因素(OR=12.0,95%CI 1.39~103.5,P=0.024)。

要点

  • 92例拟行单倍体相合移植患者中,16例(17.4%)HLA抗体阳性,6例(6.5%)DSA阳性。
  • 常规清髓性预处理移植中,DSA阴性组植入率92.3%(24/26)vs DSA阳性组25.0%(1/4)(χ²=8.433,P=0.004)。
  • DSA是影响供者干细胞植入的唯一因素(OR=12.0,95%CI 1.39~103.5,P=0.024)。

核心结论

  • DSA是导致单倍体相合造血干细胞植入失败的关键因素,移植前应进行常规检查,DSA阳性患者应选用DSA阴性供者;无合适供者时,应采取适当措施降低DSA水平以促进干细胞植入。

研究设计与样本

  • 采用免疫磁珠液相芯片技术,对2016年6月至2017年5月拟行单倍体相合造血干细胞移植患者进行HLA抗体及DSA检测,对已完成移植患者进行DSA与植入失败相关性分析。
  • 共检测了92例拟行单倍体相合造血干细胞移植患者的HLA抗体。

主要发现

  • 92例拟行单倍体相合移植患者中,16例(17.4%)存在HLA抗体,6例(6.5%)DSA阳性。
  • 常规清髓性预处理单倍体相合移植中,26例DSA阴性患者中24例成功植入(92.3%),4例DSA阳性患者中仅1例成功植入(25.0%),二组植入率差异有统计学意义(χ²=8.433,P=0.004)。
  • 多因素分析显示,DSA是影响供者干细胞植入的唯一因素(OR=12.0,95%CI 1.39~103.5,P=0.024)。
  • 6例DSA阳性患者中,4例次在移植时采取了针对DSA的措施,均获得供者干细胞顺利植入。
  • 3例HLA-Ⅰ类DSA阳性患者(首次移植2例、二次移植1例)在输入供者干细胞之前输入供者血小板,另1例HLA-Ⅰ、HLA-Ⅱ类DSA并存患者在二次移植时更换供者并给予全身放疗、利妥昔单抗及供者血小板输注。

关键数值与推荐

  • 常规清髓性预处理单倍体相合移植中,DSA阴性组植入率92.3%(24/26)vs DSA阳性组25.0%(1/4)(χ²=8.433,P=0.004)。
  • 多因素分析中DSA与植入失败的OR=12.0(95%CI 1.39~103.5),P=0.024。

临床怎么用

  • 移植前应进行常规HLA抗体及DSA检查,DSA阳性患者应选用DSA阴性供者。
  • 无合适供者时,应采取适当措施降低DSA水平以促进干细胞植入。
  • 降低DSA水平的措施包括输入供者血小板、更换供者、全身放疗及利妥昔单抗等。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effects of donor-specific HLA antibodies(DSA) for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation(haplo-HSCT) and the feasible treatment for DSA. Methods: HLA antibodies were examined using the Luminex-based single Ag assay for 92 patients who were going on haplo-SCT and the correlations of graft failure and DSA among the patients who had finished SCT were analyzed. Results: Of the total 92 patients who were going on haplo-HSCT, sixteen (17.4%) patients were HLA Ab-positive, including six (6.5%) patients with antibodies corresponding to donor HLA Ags (DSA-positive). Among the patients who had finished the haplo-HSCT with conventional myeloablative conditioning regimen, the engraftment rate was significantly higher in DSA (-) patients than that in DSA (+) patients [92.3% (24/26) vs 25.0%(1/4), χ2=8.433, P=0.004] and DSA was the only factor relevant with graft failure in multiple-factor analysis [OR=12.0(95% CI 1.39-103.5), P=0.024]. Strategies to decrease antibody levels were taken for 4 patients, two were their first transplantations, and the other two patients were their second haplo-HSCT. Three of the four patients were HLA-I-DSA positive and had gained donor engraftment by means of donor platelet transfusions to decreased the level of DSA, the fourth patient with both HLA-I and HLA-II DSA also gained engraftment with the treatments of TBI, rituximab and donor platelet transfusion. Conclusion: DSA is one of the key factors of graft failure in haplo-HSCT. Donors should be selected on the basis of an evaluation of HLA antibodies before transplantation. If haplo-HSCT from donors with DSA must be performed, then recipients should be treated for DSA to improve the chances of successful engraftment. 目的: 探讨单倍体相合造血干细胞移植中HLA供者特异性抗体(DSA)对干细胞植入的影响以及处理方法。 方法: 采用免疫磁珠液相芯片技术,对2016年6月至2017年5月拟行单倍体相合造血干细胞移植患者进行HLA抗体及DSA的检测,对已完成移植患者进行DSA与植入失败相关性分析,检测移植前后DSA水平,探索针对DSA的处理方法。 结果: 共检测了92例拟行单倍体相合造血干细胞移植患者的HLA抗体,其中16例(17.4%)存在HLA抗体,6例(6.5%)DSA阳性。在常规清髓性预处理单倍体相合移植中,26例DSA阴性患者中有24例成功植入,仅有2例发生植入失败,而采用常规预处理的4例DSA阳性患者中仅有1例成功植入,其余3例发生植入失败,二组患者植入率差异有统计学意义[92.3%(24/26)对25.0%(1/4),χ2=8.433,P=0.004]。多因素分析显示,DSA是影响供者干细胞植入的唯一因素[OR=12.0(95% CI 1.39~103.5),P=0.024]。6例DSA阳性的患者中,4例次在移植时采取了针对DSA的措施,均获得供者干细胞顺利植入,其中3例HLA-Ⅰ类DSA阳性患者(首次移植2例、二次移植1例)在输入供者干细胞之前输入供者血小板,另1例HLA-Ⅰ、HLA-Ⅱ类DSA并存患者在二次移植时更换供者并给予全身放疗、利妥昔单抗及供者血小板输注。 结论: DSA是导致单倍体相合造血干细胞植入失败的关键因素,移植前应进行常规检查,DSA阳性患者应选用DSA阴性供者;无合适供者时,应采取适当措施降低DSA水平以促进干细胞植入。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang RL, Zheng XH, Zhou LK, et al. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29562462. doi:10.3760/cma.j.issn.0253-2727.2018.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。